The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pharmaceutical Fine Chemicals Market Research Report 2024

Global Pharmaceutical Fine Chemicals Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1885957

No of Pages : 97

Ask Your Query

Synopsis

Pharmaceutical fine chemicals can be broadly defined as the set of products—intermediates and finished API, or active pharmaceutical ingredients—as well as related services like process development and optimization associated with the access by pharmaceutical companies to the drug substance (API) throughout the product life cycle excluding pre-clinical development.

The global Pharmaceutical Fine Chemicals market was valued at US$ 109680 million in 2023 and is anticipated to reach US$ 155620 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Fine Chemicals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Fine Chemicals.

Report Scope

The Pharmaceutical Fine Chemicals market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Fine Chemicals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceutical Fine Chemicals companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  • Lonza
  • CML
  • FIS
  • Hovione
  • Bachem
  • Helsinn Advanced Synthesis
  • Umicore
  • Sifavitor (Infa Group)
  • Chemo
  • W.R. Grace
  • Kenko Corporation
  • Albemarle Corporation
  • Denisco Chemicals
  • Chemada Fine Chemicals
  • Syntor Fine Chemicals
  • Johnson Matthey Fine Chemicals

Segment by Type

  • Large Molecules
  • Small Molecules

Segment by Application

  • Third Party Vendors
  • Emerging Pharmaceutical Companies
  • Established Pharmaceutical Companies

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Fine Chemicals companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Fine Chemicals Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Large Molecules
1.2.3 Small Molecules
1.3 Market by Application
1.3.1 Global Pharmaceutical Fine Chemicals Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Third Party Vendors
1.3.3 Emerging Pharmaceutical Companies
1.3.4 Established Pharmaceutical Companies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Fine Chemicals Market Perspective (2019-2030)
2.2 Pharmaceutical Fine Chemicals Growth Trends by Region
2.2.1 Global Pharmaceutical Fine Chemicals Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical Fine Chemicals Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical Fine Chemicals Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical Fine Chemicals Market Dynamics
2.3.1 Pharmaceutical Fine Chemicals Industry Trends
2.3.2 Pharmaceutical Fine Chemicals Market Drivers
2.3.3 Pharmaceutical Fine Chemicals Market Challenges
2.3.4 Pharmaceutical Fine Chemicals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Fine Chemicals Players by Revenue
3.1.1 Global Top Pharmaceutical Fine Chemicals Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical Fine Chemicals Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Fine Chemicals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Fine Chemicals Revenue
3.4 Global Pharmaceutical Fine Chemicals Market Concentration Ratio
3.4.1 Global Pharmaceutical Fine Chemicals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Fine Chemicals Revenue in 2023
3.5 Pharmaceutical Fine Chemicals Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Fine Chemicals Product Solution and Service
3.7 Date of Enter into Pharmaceutical Fine Chemicals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Fine Chemicals Breakdown Data by Type
4.1 Global Pharmaceutical Fine Chemicals Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical Fine Chemicals Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical Fine Chemicals Breakdown Data by Application
5.1 Global Pharmaceutical Fine Chemicals Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical Fine Chemicals Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Fine Chemicals Market Size (2019-2030)
6.2 North America Pharmaceutical Fine Chemicals Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical Fine Chemicals Market Size by Country (2019-2024)
6.4 North America Pharmaceutical Fine Chemicals Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Fine Chemicals Market Size (2019-2030)
7.2 Europe Pharmaceutical Fine Chemicals Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical Fine Chemicals Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical Fine Chemicals Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Fine Chemicals Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical Fine Chemicals Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical Fine Chemicals Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical Fine Chemicals Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Fine Chemicals Market Size (2019-2030)
9.2 Latin America Pharmaceutical Fine Chemicals Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical Fine Chemicals Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical Fine Chemicals Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Fine Chemicals Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical Fine Chemicals Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical Fine Chemicals Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical Fine Chemicals Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Pharmaceutical Fine Chemicals Introduction
11.1.4 Lonza Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 CML
11.2.1 CML Company Detail
11.2.2 CML Business Overview
11.2.3 CML Pharmaceutical Fine Chemicals Introduction
11.2.4 CML Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.2.5 CML Recent Development
11.3 FIS
11.3.1 FIS Company Detail
11.3.2 FIS Business Overview
11.3.3 FIS Pharmaceutical Fine Chemicals Introduction
11.3.4 FIS Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.3.5 FIS Recent Development
11.4 Hovione
11.4.1 Hovione Company Detail
11.4.2 Hovione Business Overview
11.4.3 Hovione Pharmaceutical Fine Chemicals Introduction
11.4.4 Hovione Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.4.5 Hovione Recent Development
11.5 Bachem
11.5.1 Bachem Company Detail
11.5.2 Bachem Business Overview
11.5.3 Bachem Pharmaceutical Fine Chemicals Introduction
11.5.4 Bachem Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.5.5 Bachem Recent Development
11.6 Helsinn Advanced Synthesis
11.6.1 Helsinn Advanced Synthesis Company Detail
11.6.2 Helsinn Advanced Synthesis Business Overview
11.6.3 Helsinn Advanced Synthesis Pharmaceutical Fine Chemicals Introduction
11.6.4 Helsinn Advanced Synthesis Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.6.5 Helsinn Advanced Synthesis Recent Development
11.7 Umicore
11.7.1 Umicore Company Detail
11.7.2 Umicore Business Overview
11.7.3 Umicore Pharmaceutical Fine Chemicals Introduction
11.7.4 Umicore Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.7.5 Umicore Recent Development
11.8 Sifavitor (Infa Group)
11.8.1 Sifavitor (Infa Group) Company Detail
11.8.2 Sifavitor (Infa Group) Business Overview
11.8.3 Sifavitor (Infa Group) Pharmaceutical Fine Chemicals Introduction
11.8.4 Sifavitor (Infa Group) Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.8.5 Sifavitor (Infa Group) Recent Development
11.9 Chemo
11.9.1 Chemo Company Detail
11.9.2 Chemo Business Overview
11.9.3 Chemo Pharmaceutical Fine Chemicals Introduction
11.9.4 Chemo Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.9.5 Chemo Recent Development
11.10 W.R. Grace
11.10.1 W.R. Grace Company Detail
11.10.2 W.R. Grace Business Overview
11.10.3 W.R. Grace Pharmaceutical Fine Chemicals Introduction
11.10.4 W.R. Grace Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.10.5 W.R. Grace Recent Development
11.11 Kenko Corporation
11.11.1 Kenko Corporation Company Detail
11.11.2 Kenko Corporation Business Overview
11.11.3 Kenko Corporation Pharmaceutical Fine Chemicals Introduction
11.11.4 Kenko Corporation Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.11.5 Kenko Corporation Recent Development
11.12 Albemarle Corporation
11.12.1 Albemarle Corporation Company Detail
11.12.2 Albemarle Corporation Business Overview
11.12.3 Albemarle Corporation Pharmaceutical Fine Chemicals Introduction
11.12.4 Albemarle Corporation Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.12.5 Albemarle Corporation Recent Development
11.13 Denisco Chemicals
11.13.1 Denisco Chemicals Company Detail
11.13.2 Denisco Chemicals Business Overview
11.13.3 Denisco Chemicals Pharmaceutical Fine Chemicals Introduction
11.13.4 Denisco Chemicals Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.13.5 Denisco Chemicals Recent Development
11.14 Chemada Fine Chemicals
11.14.1 Chemada Fine Chemicals Company Detail
11.14.2 Chemada Fine Chemicals Business Overview
11.14.3 Chemada Fine Chemicals Pharmaceutical Fine Chemicals Introduction
11.14.4 Chemada Fine Chemicals Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.14.5 Chemada Fine Chemicals Recent Development
11.15 Syntor Fine Chemicals
11.15.1 Syntor Fine Chemicals Company Detail
11.15.2 Syntor Fine Chemicals Business Overview
11.15.3 Syntor Fine Chemicals Pharmaceutical Fine Chemicals Introduction
11.15.4 Syntor Fine Chemicals Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.15.5 Syntor Fine Chemicals Recent Development
11.16 Johnson Matthey Fine Chemicals
11.16.1 Johnson Matthey Fine Chemicals Company Detail
11.16.2 Johnson Matthey Fine Chemicals Business Overview
11.16.3 Johnson Matthey Fine Chemicals Pharmaceutical Fine Chemicals Introduction
11.16.4 Johnson Matthey Fine Chemicals Revenue in Pharmaceutical Fine Chemicals Business (2019-2024)
11.16.5 Johnson Matthey Fine Chemicals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock